Insulet
PODD
#1459
Rank
$14.65 B
Marketcap
$208.22
Share price
-0.77%
Change (1 day)
-20.71%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total debt

Total debt on the balance sheet as of December 2025 : $0.94 Billion USD

According to Insulet's latest financial reports the company's total debt is $0.94 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Insulet - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2025-12-31$0.94 B-31.21%
2024-12-31$1.37 B-2.54%
2023-12-31$1.41 B1%
2022-12-31$1.40 B10.04%
2021-12-31$1.27 B20.26%
2020-12-31$1.05 B19.3%
2019-12-31$0.88 B49.98%
2018-12-31$0.59 B4.56%
2017-12-31$0.56 B70.14%
2016-12-31$0.33 B87.49%
2015-12-31$0.17 B4.61%
2014-12-31$0.16 B39.44%
2013-12-31$0.12 B2.98%
2012-12-31$0.11 B8.86%
2011-12-31$0.10 B56.32%
2010-12-31$69.43 M-28.4%
2009-12-31$96.97 M61.17%
2008-12-31$60.17 M125.56%
2007-12-31$26.67 M-8.71%
2006-12-31$29.22 M198.76%
2005-12-31$9.78 M88818.18%
2004-12-31$0.01 M0%
2003-12-31$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$47.93 B 4,949.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$13.86 B 1,360.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$28.07 B 2,857.33%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$42.50 B 4,377.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
$0.44 B-53.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
$1.33 B 40.37%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$1.38 B 46.41%๐Ÿ‡บ๐Ÿ‡ธ USA